A model combining TNM stage and tumor size shows utility in predicting recurrence among patients with hepatocellular carcinoma after resection

References

• FornerAReigMBruixJHepatocellular carcinomaLancet2018391101271301131429307467
   PubMed Web of Science ®Google Scholar
• GranitoABolondiLNon-transplant therapies for patients with hepatocellular carcinoma and Child-Pugh-Turcotte class B cirrhosisLancet Oncol2017182e101e11228214411
   PubMed Web of Science ®Google Scholar
• CaiSHLuSXLiuLLZhangCZYunJPIncreased expression of hepatocyte nuclear factor 4 alpha transcribed by promoter 2 indicates a poor prognosis in hepatocellular carcinomaTherap Adv Gastroenterol20171010761771
   PubMed Web of Science ®Google Scholar
• ChangK-VChenJ-DWuW-THuangK-CHsuC-THanD-SAssociation between loss of skeletal muscle mass and mortality and tumor recurrence in hepatocellular carcinoma: a systematic review and meta-analysisLiver Cancer2018719010329662836
   PubMed Web of Science ®Google Scholar
• FornerALlovetJMBruixJHepatocellular carcinomaLancet201237998221245125522353262
   PubMed Web of Science ®Google Scholar
• HirokawaFHayashiMMiyamotoYOutcomes and predictors of microvascular invasion of solitary hepatocellular carcinomaHepatol Res201444884685323834279
   PubMed Web of Science ®Google Scholar
• XiaoYLiWWanHTanYWuHCentral hepatectomy versus major hepatectomy for patients with centrally located hepatocellular carcinoma: a meta-analysisInt J Surg20185229730229530828
   PubMed Web of Science ®Google Scholar
• ButtASSharifFAbidSImpact of direct acting antivirals on occurrence and recurrence of hepatocellular carcinoma: biologically plausible or an epiphenomenon?World J Hepatol201810226727629527262
   PubMed Web of Science ®Google Scholar
• ToyodaHHiraokaATadaTCharacteristics and prognosis of hepatocellular carcinoma in Japanese patients undergoing dialysisTher Apher Dial201721546547228880488
   PubMed Web of Science ®Google Scholar
• SatoTTakahashiYImaiMIsokawaOHepatic arterial infusion chemotherapy using a reservoir for advanced hepatocellular carcinomaGan To Kagaku Ryoho2016431737726809529
   PubMedGoogle Scholar
• BorzioMDionigiERossiniAExternal validation of the ITA. LI.CA prognostic system for patients with hepatocellular carcinoma: a multicenter cohort studyHepatology2017
   Google Scholar
• YangZYePXuQElevation of serum GGT and LDH levels, together with higher BCLC staging are associated with poor overall survival from hepatocellular carcinoma: a retrospective analysisDiscov Med20151910740941826175398
   PubMed Web of Science ®Google Scholar
• YuSJKwonJHKimWInitial alpha-fetoprotein response predicts prognosis in hepatitis B-related solitary HCC patients after radiofrequency ablationJ Clin Gastroenterol2018523e18e2628795996
   PubMed Web of Science ®Google Scholar
• LeeKLeeKBYiNJSuhKSJangJJPrognosis of hepatocellular carcinoma after liver transplantation: comparative analysis with partial hepatectomyJ Pathol Transl Med2017511798628013531
   PubMedGoogle Scholar
• KohKCLeeHChoiMSClinicopathologic features and prognosis of combined hepatocellular cholangiocarcinomaAm J Surg2005189112012515701504
   PubMed Web of Science ®Google Scholar
• IkedaKSaitohSTsubotaARisk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinomaCancer199371119258380116
   PubMed Web of Science ®Google Scholar
• EdgeSBComptonCCThe American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNMAnn Surg Oncol20101761471147420180029
   PubMed Web of Science ®Google Scholar
• CaiSCaoJYuTXiaMPengJEffectiveness of entecavir or telbivudine therapy in patients with chronic hepatitis B virus infection pre- treated with interferon compared with de novo therapy with entecavir and telbivudineMedicine20179622e702128562554
   PubMed Web of Science ®Google Scholar
• CaiSOuZLiuDRisk factors associated with liver steatosis and fibrosis in chronic hepatitis B patient with component of metabolic syndromeUnited European Gastroenterol J201864558566
   PubMed Web of Science ®Google Scholar
• OuHCaiSLiuYXiaMPengJA noninvasive diagnostic model to assess nonalcoholic hepatic steatosis in patients with chronic hepatitis BTherap Adv Gastroenterol2017102207217
   PubMed Web of Science ®Google Scholar
• XueXCaiSOuHZhengCWuXHealth-related quality of life in patients with chronic hepatitis B during antiviral treatment and off- treatmentPatient Prefer Adherence201711859328138226
   PubMed Web of Science ®Google Scholar
• HoSYLiuPHHsuCYPrognostic performance of ten liver function models in patients with hepatocellular carcinoma undergoing radiofrequency ablationSci Rep20188184329339752
   PubMedGoogle Scholar
• NaSKYimSYSuhSJALBI versus Child-Pugh grading systems for liver function in patients with hepatocellular carcinomaJ Surg Oncol2018117591292129448306
   PubMed Web of Science ®Google Scholar
• ChangKVChenJDWuWTHuangKCHsuCTHanDSAssociation between loss of skeletal muscle mass and mortality and tumor recurrence in hepatocellular carcinoma: a systematic review and meta-analysisLiver Cancer2018719010329662836
   PubMed Web of Science ®Google Scholar
• ShenJLiuJLiCWenTYanLYangJThe prognostic significance of serum HBeAg on the recurrence and long-term survival after hepatectomy for hepatocellular carcinoma: a propensity score matching analysisJ Viral Hepat2018
   Web of Science ®Google Scholar
• KomorowskiALHsuCCJulkaKDAFP role in predicting recurrence of hepatocellular carcinoma after living donor liver transplantation in HCV patientsNeoplasma201865345546029788730
   PubMed Web of Science ®Google Scholar
• XueXCaiSComment on “Assessment of liver stiffness in pediatric fontan patients using transient elastography”Can J Gastroenterol Hepatol201620169343960228025635
   PubMedGoogle Scholar
• HuangGLiPPLauWYAntiviral therapy reduces hepatocellular carcinoma recurrence in patients with low HBV-DNA levels: a randomized controlled trialAnn Surg20181
   Google Scholar
• YangXGaoJYWangJChengJThe impact of anti-HBV treatment on the occurrence and recurrence of hepatocellular carcinoma: focus on Asian studiesDiscov Med201519103899925725223
   PubMed Web of Science ®Google Scholar
• ZhangLXieXYChenYHepatitis B surface antigen predicts recurrence after radiofrequency ablation in patients with low hepatitis B virus loadsMedicine20179652e937729384914
   PubMed Web of Science ®Google Scholar
• ZengJCaiSLiuJXueXWuXZhengCDynamic changes in liver stiffness measured by transient elastography predict clinical outcomes among patients with chronic hepatitis BJ Ultrasound Med201736226126827914175
   PubMed Web of Science ®Google Scholar
• CaiSYuTJiangYZhangYLvFPengJComparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week resultClin Exp Med201616342943626164128
   PubMed Web of Science ®Google Scholar
• CaiSLiZYuTXiaMPengJSerum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogsInfect Drug Resist20181146947729662321
   PubMed Web of Science ®Google Scholar
• GanWHuangJLZhangMXNew nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resectionJ Surg Oncol201811771540154729572833
   PubMed Web of Science ®Google Scholar
• TokumitsuYSakamotoKTokuhisaYA new prognostic model for hepatocellular carcinoma recurrence after curative hepatectomyOncol Lett20181544411442229556288
   PubMed Web of Science ®Google Scholar
• McpeakeJRO’GradyJGZamanSLiver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcomeJ Hepatol19931822262347691926
   PubMed Web of Science ®Google Scholar
• GaoQWangXYQiuSJTumor stroma reaction-related gene signature predicts clinical outcome in human hepatocellular carcinomaCancer Sci201110281522153121564420
   PubMed Web of Science ®Google Scholar
• ZimmermanMATrotterJFWachsMPredictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experienceTranspl Int200720974775317565579
   PubMed Web of Science ®Google Scholar
• NotarpaoloALayeseRMagistriPValidation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCCJ Hepatol201766355255927899297
   PubMed Web of Science ®Google Scholar
• LiDSatomuraSBiomarkers for hepatocellular Carcinoma (HCC): an updateAdv Exp Med Biol201586717919326530367
   PubMed Web of Science ®Google Scholar
• ToyodaHKumadaTTadaTSoneYKaneokaYMaedaATumor markers for hepatocellular carcinoma: simple and significant predictors of outcome in patients with HCCLiver Cancer20154212613626020034
   PubMed Web of Science ®Google Scholar
• BaigJAAlamJMMahmoodSRHepatocellular carcinoma (HCC) and diagnostic significance of A-fetoprotein (AFP)J Ayub Med Coll Abbottabad20092117275
   PubMedGoogle Scholar
• DuZGWeiYGChenKFLiBRisk factors associated with early and late recurrence after curative resection of hepatocellular carcinoma: a single institution’s experience with 398 consecutive patientsHepatobiliary Pancreat Dis Int2014131536124686542
   PubMed Web of Science ®Google Scholar